The White House is reportedly considering an executive order to fire thousands of HHS employees. If implemented within the ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

The FDA has made some modest efforts, but it needs an internal organization that understands and would be an aggressive ...

Zuckerman is president of the National Center for Health Research and a former congressional investigator on FDA approval standards. Powers is professor of clinical medicine at George Washington ...

Biologics are the newest class of psoriasis drugs approved by the Food and Drug Administration (FDA ... according to 2023 research. Some biologics can be much more expensive.

As per DelveInsight estimates, North America is anticipated to dominate the global biologics drug substance manufacturing market during the forecast period. In the biologics type segment of the ...

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics and headquartered in Switzerland, ...

MIRAMAR, Fla. - HCW Biologics Inc. (NASDAQ: HCWB), a clinical-stage biopharmaceutical company with a market capitalization of approximately $12.4 million, announced today that it has received U.S.